Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ownership Breakdown Dr. Reddy's Laboratories Ltd RDY

Headquartered in India, Dr. Reddy's Laboratories develops and manufactures generic pharmaceutical products sold across the world. The company specializes in low-cost, easy-to-produce small-molecule generic drugs and active pharmaceutical ingredients. Its drug portfolio in recent years has included biosimilar drug launches in select emerging markets and has shifted toward injectables and more complex generic products. Geographically, the company's sales are well dispersed across North America, India, and other emerging markets.


Top institutional share ownership of Dr. Reddy's Laboratories Ltd.

Name Shares Shares % change Value Value % change
Royal Bank Of Canada 3,233,895 -3.8% $179,126 -4.4%
Renaissance Technologies Llc 2,037,738 6.6% $112,870 5.9%
BlackRock Inc. 1,611,731 1.8% $89,273 1.1%
REEAX - RBC Emerging Markets Equity Fund Class A 1,248,144 -6.0% $69,580 -7.4%
Vanguard Group Inc 1,086,510 -3.9% $60,182 -4.4%
IEMG - iShares Core MSCI Emerging Markets ETF 1,033,233 3.8% $57,896 7.7%
Morgan Stanley 999,764 102.0% $55,376 100.8%
State Street Corp 766,809 -15.2% $42,474 -15.7%
Dimensional Fund Advisors Lp 765,066 15.8% $42,357 15.0%
Goldman Sachs Group Inc 742,499 -0.3% $41,128 -0.9%

Top institutional buyers of Dr. Reddy's Laboratories Ltd.

Name Shares % change Value % change Shares Value
Morgan Stanley 102.0% 100.8% 999,764 $55,376
DFCEX - Emerging Markets Core Equity Portfolio - Institutional Class 90.2% 89.3% 269,900 $13,900
EEMV - iShares Edge MSCI Min Vol Emerging Markets ETF 71.9% 78.3% 477,174 $26,738
Dimensional Fund Advisors Lp 15.8% 15.0% 765,066 $42,357
EEM - iShares MSCI Emerging Markets ETF 10.6% 14.8% 469,195 $26,291
FEMVX - Fidelity SAI Emerging Markets Value Index Fund 10.5% 6.2% 264,588 $13,675
TEMRX - TIAA-CREF Emerging Markets Equity Fund Retail Class 8.5% 1.0% 202,857 $10,925
Renaissance Technologies Llc 6.6% 5.9% 2,037,738 $112,870
Parametric Portfolio Associates Llc 5.1% -10.5% 399,303 $22,253
IEMG - iShares Core MSCI Emerging Markets ETF 3.8% 7.7% 1,033,233 $57,896

Top institutional sellers of Dr. Reddy's Laboratories Ltd.

Name Shares % change Value % change Shares Value
VGTSX - Vanguard Total International Stock Index Fund Investor Shares -82.8% -82.8% 231,918 $11,944
VEIEX - Vanguard Emerging Markets Stock Index Fund Investor Shares -50.8% -51.1% 554,284 $28,546
Jpmorgan Chase & Co -44.2% -44.5% 281,669 $15,601
D. E. Shaw & Co., Inc. -19.1% -19.6% 245,023 $13,572
State Street Corp -15.2% -15.7% 766,809 $42,474
REEAX - RBC Emerging Markets Equity Fund Class A -6.0% -7.4% 1,248,144 $69,580
INDA - iShares MSCI India ETF -5.3% -1.8% 661,392 $37,060
Vanguard Group Inc -3.9% -4.4% 1,086,510 $60,182
Royal Bank Of Canada -3.8% -4.4% 3,233,895 $179,126
Mondrian Investment Partners LTD -1.6% -2.2% 296,130 $16,403

Information provided by Fintel.io